CAS 501938-01-8: (1'R,2S,4aR,5'R,5aR,7R,7aR,7bR,8R,10R,11aS,12aS,12bS,14aR)-1,1,5',7a,8,12a-hexamethyl-2-(beta-D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate

Natural glycoside

23-epi-26-Deoxyactein is a naturally occurring compound exhibiting anti-obesity and anti-cancer properties when administered orally [1] [2] [3].

Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives

23-Epi-26-deoxyactein is a triterpene glycoside, which is derived from the roots of the plant *Actaea racemosa*, commonly known as black cohosh. As a phytochemical, it belongs to a group of compounds known as saponins, which are characterized by their glycosidic linkages and steroidal or triterpenoid aglycones. The mode of action of 23-Epi-26-deoxyactein involves modulating various biological pathways, including the regulation of inflammatory responses and hormonal pathways. It has been studied for its ability to influence estrogen receptor activity, making it a subject of interest in the context of menopausal symptom relief. Its uses and applications are primarily in the field of phytotherapy, where it is researched for potential benefits in alleviating conditions such as menopausal symptoms, osteoporosis, and inflammation-related disorders. While its exact mechanisms and efficacy continue to be explored, it presents a promising area for therapeutic development and biochemical research, particularly in studying its interactions with hormonal and inflammatory processes.